Literature DB >> 25893054

Sodium valproate induced necrotising pancreatitis: A case report.

M F Ali1, K Y Loh2.   

Abstract

Sodium valproate is one of the most common first-line antiepileptics prescribed for primary and secondary generalised seizures. However, serious complications associated with sodium valproate, such as acute pancreatitis, need to be considered when choosing this medication for treating epilepsy in certain populations such as children and persons with intellectual disability. We report a case of a 21-year-old man with intellectual disability who presented to the emergency department with an acute abdomen, vomiting and diarrhoea. He had to undergo an emergency exploratory laparotomy during which acute necrotising pancreatitis was diagnosed intra-operatively. We believe that the recent increase in sodium valproate dosage for his epilepsy was the cause of the pancreatitis. Carers of such persons should be adequately informed regarding possible life-threatening complications of medications prescribed to avoid delay in diagnosis and unwanted incidents.

Entities:  

Keywords:  anticonvulsants; complications; drug induced; intellectual disability/mental retardation; pancreatitis; valproic acid

Year:  2013        PMID: 25893054      PMCID: PMC4400686     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  11 in total

Review 1.  Acute necrotizing pancreatitis.

Authors:  T H Baron; D E Morgan
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

Review 2.  Fatal pancreatitis associated with valproic acid: review of the literature.

Authors:  Kambiz Yazdani; Michael Lippmann; Indira Gala
Journal:  Medicine (Baltimore)       Date:  2002-07       Impact factor: 1.889

3.  The difficulties of diagnosing VPA-induced pancreatitis in children with severe motor and intellectual disabilities.

Authors:  Hideto Yoshikawa
Journal:  Eur J Paediatr Neurol       Date:  2004       Impact factor: 3.140

Review 4.  L-carnitine for acute valproic acid overdose: a systematic review of published cases.

Authors:  Jerrold Perrott; Nancy G Murphy; Peter J Zed
Journal:  Ann Pharmacother       Date:  2010-06-29       Impact factor: 3.154

Review 5.  Drug induced pancreatitis.

Authors:  Claudia J Nitsche; Nigel Jamieson; Markus M Lerch; Julia V Mayerle
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-04       Impact factor: 3.043

6.  Pancreatitis associated with valproic acid therapy.

Authors:  P B Batalden; B J Van Dyne; J Cloyd
Journal:  Pediatrics       Date:  1979-10       Impact factor: 7.124

Review 7.  Valproic acid-induced pancreatitis: 16 new cases and a review of the literature.

Authors:  Thorsten Gerstner; Deike Büsing; Nellie Bell; Elke Longin; Johannes-Martin Kasper; Wolfgang Klostermann; Burkhard Hebing; Folker Hanefeld; Ulrich Eckel; Reiner Hoffmann; Ulrich Bettendorf; Birgit Weidner; Adelheid Wiemer-Kruel; Knut Brockmann; Fritz-Wilhelm Neumann; Thorsten Sandrieser; Markus Wolff; Stephan König
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

Review 8.  Acute pancreatitis in children from Valproic acid: case series and review.

Authors:  Nancy L Grauso-Eby; Olga Goldfarb; Lori B Feldman-Winter; Gary N McAbee
Journal:  Pediatr Neurol       Date:  2003-02       Impact factor: 3.372

Review 9.  Valproic acid-induced acute pancreatitis and multiorgan failure in a child.

Authors:  Ayhan Yaman; Tanl Kendirli; Cağlar Odek; Omer Bektaş; Zarife Kuloğlu; Meltem Koloğlu; Erdal Ince; Gülhis Deda
Journal:  Pediatr Emerg Care       Date:  2013-05       Impact factor: 1.454

10.  Valproate associated acute pancreatitis.

Authors:  A E Hamad; M E Fawzi
Journal:  Neurosciences (Riyadh)       Date:  2000-07       Impact factor: 0.906

View more
  1 in total

1.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.